Biogen Vs. AbbVie Industry Stock Comparison

Sell

30

BIIB
Biogen

Last Price:

146.74

Seasonality Move:

8.89%

Sell

42

ABBV
AbbVie

Last Price:

172.87

Seasonality Move:

1.78%

Sell

30

Biogen (BIIB) is a Sell

Is Biogen a Buy, Sell or Hold?

The current Biogen [BIIB] share price is $150.64. The Score for BIIB is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
BIIB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

42

AbbVie (ABBV) is a Sell

Is AbbVie a Buy, Sell or Hold?

The current AbbVie [ABBV] share price is $175.38. The Score for ABBV is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
ABBV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BIIB Stock Price Chart

What is Biogen's stock price today?

The Biogen share price today is $150.64
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIIB is experiencing selling pressure, which indicates risk of future bearish movement.

ABBV Stock Price Chart

What is AbbVie's stock price today?

The AbbVie share price today is $175.38
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABBV is experiencing buying pressure, which is a positive indicator for future bullish movement.

BIIB Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-5.04	Sell
Relative Strength Index (14 RSI):	27.31	Sell
Chaikin Money Flow:	-922714	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(154.06 - 162.8)	Sell
Bollinger Bands (100):	(167.12 - 203.9)	Sell

ABBV Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-2.65	Sell
Relative Strength Index (14 RSI):	44.43	Sell
Chaikin Money Flow:	4702546	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(169.34 - 179.6)	Buy
Bollinger Bands (100):	(179.01 - 198.23)	Sell

BIIB Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	154.31	Sell
20-day SMA:	157.2	Sell
50-day SMA:	170.23	Sell
200-day SMA:	202.59	Sell
8-day EMA:	153.81	Sell
20-day EMA:	158.17	Sell
50-day EMA:	168.83	Sell
200-day EMA:	199.72	Sell

ABBV Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	174.55	Buy
20-day SMA:	175.97	Sell
50-day SMA:	184.1	Sell
200-day SMA:	178.88	Sell
8-day EMA:	174.66	Buy
20-day EMA:	176.79	Sell
50-day EMA:	181.56	Sell
200-day EMA:	178.36	Sell

Biogen Earnings Growth & BIIB Earnings Dates

Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.45 per share, and an increase next year of $0.14 per share.

AbbVie Earnings Growth & ABBV Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $1.24 per share.

Biogen Technical Analysis

	Dec 4	Dec 5	Dec 6	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13	Dec 16	Dec 17
	Dec
	04	05	06	09	10	11	12	13	16	17
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

AbbVie Technical Analysis

	Dec 4	Dec 5	Dec 6	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13	Dec 16	Dec 17
	Dec
	04	05	06	09	10	11	12	13	16	17
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):